AstraZeneca posted a 42% fall in first-quarter profit, below analyst expectations, as sales of its best-selling drugs continued to be dented by generic competition.
WSJ.com: What's News US, Wall Street Journal: Home US
Wed, 04/23/2014 - 11:44pm
AstraZeneca posted a 42% fall in first-quarter profit, below analyst expectations, as sales of its best-selling drugs continued to be dented by generic competition.